Researchers at the Lomonosov Moscow State University used a mouse model of a mitochondria-targeted antioxidant to study treatment of diabetic wounds, and are publishing their results in the journal Oxidative Medicine and ...
Jun 30, 2017
0
0
Insulin degludec (trade name: Tresiba) has been approved since January 2015 for adolescents and children from the age of one year with type 1 or type 2 diabetes mellitus. In an early benefit assessment pursuant to the Act ...
Jun 1, 2015
0
6
New research published in Diabetologia (the journal of the European Association for the Study of Diabetes) shows that in women who have developed gestational diabetes mellitus (GDM) during pregnancy, being obese before the ...
Mar 18, 2015
0
14
Research performed by the University of Veracruz (UV), in the east coast of Mexico, called Lifestyles Nutrition Students and Risk of Type II Diabetes, showed that the lifestyle choices of young people between 17 and 24 years ...
Nov 18, 2014
0
0
The Universitat Politècnica de València, the Instituto de Investigación Sanitaria (INCLIVA) of the Hospital Clínico Universitario de Valencia, the Hospital Clínic de Barcelona and the Polytechnic School of the Universitat ...
May 23, 2014
0
0
Melatonin is a natural hormone segregated by the body and melatonin levels generally increase in the dark at night. It is also found in fruit and vegetables like mustard, Goji berries, almonds, sunflower seeds, cardamom, ...
Sep 25, 2013
0
1
The DiMelli (Diabetes Mellitus Incidence Cohort Registry) study examines the frequency and characteristics of diabetes phenotypes in children and young adults below the age of 20. The study was commissioned to investigate ...
Sep 12, 2013
0
0
Patients with type 2 diabetes and high cardiovascular risk due to recent acute coronary syndromes had similar rates of cardiovascular events when treated with the anti-diabetic agent alogliptin compared to placebo according ...
Sep 2, 2013
0
0
Lixisenatide (trade name: Lyxumia) has been approved in Germany since February 2013 for the treatment of type 2 diabetes mellitus in combination with oral blood-glucose lowering drugs or basal insulin when these, together ...
Aug 2, 2013
0
0
Dapagliflozin (trade name: Forxiga) has been approved in Germany since November 2012 for the treatment of type 2 diabetes mellitus. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal ...
Jun 6, 2013
0
0
